Lexeo Therapeutics News

Lexeo Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

04:44

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan

Aug 14 06:37

Lexeo Therapeutics | 424B3: Prospectus

Aug 12 19:15

Lexeo Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 19:05

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 12 19:05

Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eventide Asset Management, LLC(6.65%),Finny Kuruvilla, M.D. Ph. D.(6.65%), etc.

Aug 9 21:47

Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)

Aug 6 00:57

Lexeo Therapeutics | 424B3: Prospectus

Jul 15 20:04

Lexeo Therapeutics | 8-K: Current report

Jul 15 19:59

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan

Jul 13 04:58

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Van Hauwermeiren Timothy

Jul 9 06:27

Lexeo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Van Hauwermeiren Timothy

Jul 9 06:23

Lexeo Therapeutics | 424B3: Prospectus

Jul 8 19:07

Lexeo Therapeutics | 8-K: Current report

Jul 8 19:02

Lexeo Therapeutics | 424B3: Prospectus

Jun 28 19:37

Lexeo Therapeutics | 8-K: Current report

Jun 28 19:36

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA

Jun 28 05:10

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Altschuler Steven

Jun 28 05:09

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DIAZ REINALDO M

Jun 28 05:08

Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Agger Mette Kirstine

Jun 28 05:04